These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 33009223)

  • 1. Tolterodine in the Treatment of Clozapine-Associated Urinary Incontinence: A Case Report.
    Selvaraj S; Parlikar R; Damodharan D; Narayanaswamy JC; Venkatasubramanian G
    J Clin Psychopharmacol; 2020; 40(6):634-635. PubMed ID: 33009223
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapy of mixed urinary incontinence].
    Goepel M
    Urologe A; 2003 Jun; 42(6):812-7. PubMed ID: 12851773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Failure of tolterodine to treat clozapine-induced nocturnal enuresis.
    English BA; Still DJ; Harper J; Saklad SR
    Ann Pharmacother; 2001; 35(7-8):867-9. PubMed ID: 11485135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective randomized trial comparing the use of tolterodine or weighted vaginal cones in women with overactive bladder syndrome.
    Yüce T; Dökmeci F; Çetinkaya ŞE
    Eur J Obstet Gynecol Reprod Biol; 2016 Feb; 197():91-7. PubMed ID: 26720597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No evidence for association of alpha 1a adrenoceptor gene polymorphism and clozapine-induced urinary incontinence.
    Hsu JW; Wang YC; Lin CC; Bai YM; Chen JY; Chiu HJ; Tsai SJ; Hong CJ
    Neuropsychobiology; 2000; 42(2):62-5. PubMed ID: 10940760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bethanechol and Aripiprazole for the management of refractory urinary incontinence in a patient on Clozapine.
    Dadlani N; Austin M
    Aust N Z J Psychiatry; 2016 Feb; 50(2):182. PubMed ID: 25922356
    [No Abstract]   [Full Text] [Related]  

  • 7. A retrospective study of clozapine and urinary incontinence in Chinese in-patients.
    Lin CC; Bai YM; Chen JY; Lin CY; Lan TH
    Acta Psychiatr Scand; 1999 Aug; 100(2):158-61. PubMed ID: 10480202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mirabegron or tolterodine for the treatment of overactive bladder in Japan: Which drug is more cost-effective as the first-line treatment?
    Yamanishi Y; Yamanishi T; Tajima H; Ikeda S
    Int J Urol; 2018 Oct; 25(10):863-870. PubMed ID: 30112772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biperiden for excessive sweating from clozapine.
    Richardson C; Kelly DL; Conley RR
    Am J Psychiatry; 2001 Aug; 158(8):1329-30. PubMed ID: 11481174
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of tolterodine with standard treatment in pediatric patients with non-neurogenic dysfunctional voiding/over active bladder: a systematic review.
    Medhi B; Mittal N; Bansal D; Prakash A; Sarangi SC; Nirthi B
    Indian J Physiol Pharmacol; 2013; 57(4):343-53. PubMed ID: 24968572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of urge-predominant mixed urinary incontinence with tolterodine extended release: a randomized, placebo-controlled trial.
    Wein AJ
    J Urol; 2005 Jun; 173(6):2056-7. PubMed ID: 15879827
    [No Abstract]   [Full Text] [Related]  

  • 12. Modern pharmacotherapy of urge urinary incontinence in the USA: tolterodine and oxybutynin.
    Rovner ES; Wein AJ
    BJU Int; 2000 Oct; 86 Suppl 2():44-53; discussion 53-4. PubMed ID: 11501617
    [No Abstract]   [Full Text] [Related]  

  • 13. Clozapine-induced urinary incontinence: incidence and treatment with ephedrine.
    Fuller MA; Borovicka MC; Jaskiw GE; Simon MR; Kwon K; Konicki PE
    J Clin Psychiatry; 1996 Nov; 57(11):514-8. PubMed ID: 8968299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tolterodine: a safe and effective treatment for older patients with overactive bladder.
    Malone-Lee JG; Walsh JB; Maugourd MF
    J Am Geriatr Soc; 2001 Jun; 49(6):700-5. PubMed ID: 11454106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of two doses of tolterodine versus placebo in patients with detrusor overactivity and symptoms of frequency, urge incontinence, and urgency: urodynamic evaluation. The International Study Group.
    Jonas U; Höfner K; Madersbacher H; Holmdahl TH
    World J Urol; 1997; 15(2):144-51. PubMed ID: 9144906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tolterodine, a new antimuscarinic drug for treatment of bladder overactivity--a comment.
    Short DD
    Pharmacotherapy; 1999 Oct; 19(10):1188. PubMed ID: 10512072
    [No Abstract]   [Full Text] [Related]  

  • 17. Urinary incontinence management: new questions from old assumptions.
    DuBeau CE
    J Am Geriatr Soc; 2001 Jun; 49(6):829-30. PubMed ID: 11454125
    [No Abstract]   [Full Text] [Related]  

  • 18. Clozapine Discontinuation and Malignant Catatonia: A Case Report.
    Kapulsky L; Greiner MG; Daniels JE; Gordon-Elliott JS
    Psychosomatics; 2019; 60(1):75-79. PubMed ID: 29703551
    [No Abstract]   [Full Text] [Related]  

  • 19. Trihexyphenidyl treatment of clozapine-induced hypersalivation.
    Spivak B; Adlersberg S; Rosen L; Gonen N; Mester R; Weizman A
    Int Clin Psychopharmacol; 1997 Jul; 12(4):213-5. PubMed ID: 9347382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clozapine-associated asterixis: case report.
    Kwak YT; Yang Y; Koo MS
    J Clin Psychopharmacol; 2014 Feb; 34(1):165-7. PubMed ID: 24158019
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.